drug

KB111

1 story · latest Jul 21, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Krystal Biotech, Inc.

Timeline

Krystal Biotech registers early-phase trial of KB111 gene therapy for Hailey-Hailey Disease

Jul 21Trial updateKB111 Krystal Biotech, Inc.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.